Insulet (PODD) Competitors

Insulet (NASDAQ:PODD) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and community ranking.

Which has stronger valuation and earnings, PODD or BDX?

Becton, Dickinson and Company has higher revenue and earnings than Insulet. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$1.70B	11.40	$206.30M	$5.84	47.23
Becton, Dickinson and Company	$20.18B	3.41	$1.71B	$5.94	40.00

Which has more risk and volatility, PODD or BDX?

Insulet has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.39, indicating that its share price is 61% less volatile than the S&P 500.

Is PODD or BDX more profitable?

Insulet has a net margin of 21.22% compared to Becton, Dickinson and Company's net margin of 8.55%. Insulet's return on equity of 27.98% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insulet	21.22%	27.98%	9.16%
Becton, Dickinson and Company	8.55%	14.89%	6.98%

Does the media prefer PODD or BDX?

In the previous week, Becton, Dickinson and Company had 17 more articles in the media than Insulet. MarketBeat recorded 28 mentions for Becton, Dickinson and Company and 11 mentions for Insulet. Insulet's average media sentiment score of 0.95 beat Becton, Dickinson and Company's score of 0.81 indicating that Insulet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	6 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Becton, Dickinson and Company	17 Very Positive mention(s)	0 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer PODD or BDX?

Insulet currently has a consensus target price of $272.81, suggesting a potential downside of 1.09%. Becton, Dickinson and Company has a consensus target price of $283.50, suggesting a potential upside of 19.33%. Given Becton, Dickinson and Company's stronger consensus rating and higher probable upside, analysts plainly believe Becton, Dickinson and Company is more favorable than Insulet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.81
Becton, Dickinson and Company	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community believe in PODD or BDX?

Insulet received 131 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 66.30% of users gave Insulet an outperform vote while only 62.32% of users gave Becton, Dickinson and Company an outperform vote.

Company	Underperform	Outperform
Insulet	Outperform Votes 728 66.30%	Underperform Votes 370 33.70%
Becton, Dickinson and Company	Outperform Votes 597 62.32%	Underperform Votes 361 37.68%

Do institutionals & insiders hold more shares of PODD or BDX?

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. 0.5% of Insulet shares are owned by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Insulet beats Becton, Dickinson and Company on 11 of the 18 factors compared between the two stocks.